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Importance 
Monkeypox is a viral disease that resembles smallpox, but unlike smallpox, is 
acquired from animals. Monkeypox virus is endemic in western and central Africa, 
where it circulates in unknown animal hosts and emerges periodically to affect humans. 
The consequences range from asymptomatic infections to severe, fatal illness. This 
virus also causes illness in nonhuman primates, and outbreaks have been seen 
occasionally in primate facilities, in various parts of the world. The only outbreak of 
human monkeypox reported outside Africa occurred in the United States in 2003. The 
virus entered North America in exotic African rodents imported as pets, and spread to 
pet prairie dogs, which were highly susceptible to infection. This virus subsequently 
infected approximately 70 people who had been in contact with these animals. Prompt 
diagnosis of monkeypox is essential, to prevent this disease from becoming established 
outside Africa. In addition, it must be distinguished from smallpox, which has been 
eradicated from human populations but is a potential bioterrorist weapon. 
Etiology 
Monkeypox results from infection by the monkeypox virus, a member of the 
genus Orthopoxvirus in the family Poxviridae (subfamily Chordopoxvirinae). Two 
clades of monkeypox viruses, the West African and Congo Basin viruses, have been 
identified. The Congo Basin viruses are more virulent. Monkeypox virus is closely 
related to some other orthopoxviruses such as variola (smallpox) virus, and it cannot 
be distinguished from these viruses in some laboratory tests.  
Monkeypox should not be confused with benign epidermal monkeypox (BEMP), 
a poxviral disease of primates caused by tanapox virus, an antigenically unrelated 
virus in the genus Yatapoxvirus of the family Poxviridae.  
Species Affected 
The monkeypox virus’s full host range is unknown. Species known to be 
susceptible to infection include diverse Old and New World monkeys and apes, and a 
variety of rodents and other small mammals. Two genera of African squirrels, 
Funisciurus spp. (rope squirrels) and Heliosciurus spp. (sun squirrels), have high 
seroprevalence rates, and have been suggested as possible maintenance hosts or 
vectors in Africa. Sun squirrels did not seem to be susceptible in the U.S. outbreak, 
which was caused by a West African virus; however, it is possible that they are 
reservoir hosts only for the Congo Basin clade. Another possibility is that African 
squirrels are incidental hosts. A recent study in Ghana (West Africa) found evidence 
of intermittent orthopoxvirus exposure in rodents of the genera Cricetomys, 
Graphiurus and Funisciurus, as well as in African ground squirrels (Xerus spp.), but 
it did not implicate any single species as a monkeypox reservoir host.  
During the U.S. outbreak, a number of species were exposed to a West African 
monkeypox virus, many at the exotic animal importer where the shipment of infected 
animals arrived. Infected animals included Gambian giant pouched rats (Cricetomys 
spp.), rope squirrels, dormice (Graphiurus sp.), a groundhog/ woodchuck (Marmota 
monax), an African hedgehog (Atelerix sp.), a jerboa (Jaculus sp.) and two opossums 
(Didelphis marsupialis and Monodelphis domestica). North American black-tailed 
prairie dogs (Cynomys ludovicianus) were readily infected by this virus. Chinchillas 
(Chinchilla lanigera) and coatimundis (Nasua nasua) developed antibodies after 
exposure, but viral DNA or infectious virus was not found. Two cusimanse 
(Crossarchus obscurus), a genet (Genetta genetta) and 27 sun squirrels (Heliosciurus 
gambianus) in the infected shipment had no evidence of infection. Experimental 
infections with monkeypox virus have been established in prairie dogs, dormice, 
ground squirrels (Spermophilus tridecemlineatus), the cotton rat (Sigmodon hispidus) 
and the multimammate mouse (Mastomys natalensis). Anteaters were thought to have 
been involved in an outbreak among primates at the Rotterdam Zoo, the Netherlands 
in 1964. 
Zoonotic potential 
Both clades of monkeypox virus are zoonotic.  
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Geographic Distribution 
Monkeypox is endemic in central Africa (the Congo 
Basin) and West Africa. An outbreak of human monkeypox 
occurred in the U.S. in 2003, but there is no evidence that 
the virus became established in North America. 
Transmission 
The transmission of monkeypox virus between prairie 
dogs is still incompletely understood. In these animals, the 
virus or its nucleic acids have been found in skin lesions, 
urine, feces, and oral, nasal and conjunctival exudates. In 
terminal cases, it appears to be widely distributed in the 
tissues. Experimental infections have been established in 
prairie dogs by intranasal inoculation or contact with 
fomites (bedding from an animal with lesions). Aerosol 
transmission might also be possible; however, this is still 
not entirely certain, as the experimental design did not rule 
out the possibility of nose-to-nose contact between cages. 
Experimentally infected prairie dogs can shed monkeypox 
viruses until 21 days after inoculation. 
There is little published information on transmission 
routes in other small animal pets. Monkeypox virus has 
been found in most tissues of dormice, and limited evidence 
suggests that some small animals, such as dormice and 
Gambian giant pouched rats, might carry this virus for a 
few weeks or months. Viral DNA was detected in the 
tissues, urine and feces of one dormouse for at least 6 
months, but no viral antigens were found when this animal 
was euthanized. Whether such animals shed infectious virus 
is not known.  
Monkeypox virus can be transmitted to people in bites 
from animals, in aerosols during close contact, or by 
direct contact with lesions, blood or body fluids. In Africa, 
human outbreaks have often been linked to handling, 
preparing and eating wild animals. In the U.S., most cases 
occurred among people who had close direct contact with 
prairie dogs; some infections were apparently acquired in 
scratches and bites, or through open wounds. Person-to-
person transmission can also occur. In people, monkeypox 
virus has been isolated for up to 18 days after the onset of 
the rash. Potential routes of transmission between people 
include contact with skin lesions or infectious body fluids, 
or aerosol transmission during prolonged face-to-face 
contact. Transmission between humans appears to 
relatively inefficient, and sustained person-to-person 
spread has not been reported. Until 2005, the longest 
documented chain was four serial transmissions. More 
efficient person-to-person spread, with six serial 
transmissions, was later reported from an outbreak in the 
Republic of Congo. It is possible that the efficiency of 
transmission differs between viruses.  
Disinfection 
The U.S. Centers for Disease Control and Prevention 
(CDC) recommends disinfection of contaminated surfaces 
with 0.5% sodium hypochlorite or other EPA–approved 
high–level disinfectants. Incineration or autoclaving is 
appropriate for some contaminated materials. Burial 
without decontamination is not recommended. 
Infections in Animals 
Incubation Period 
Reported incubation periods are 4 to 13 days in 
experimentally infected black-tailed prairie dogs, 11 to 18 
days in 3 prairie dogs infected by exposure to fomites, and 
4 to 5 days in experimentally infected ground squirrels. In 
two studies, experimentally infected cynomolgus monkeys 
developed clinical signs 3 to 7 days after aerosol exposure. 
Clinical Signs 
Nonhuman primates 
In nonhuman primates, the predominant syndrome is a 
self–limiting rash. The initial clinical signs include fever 
and 1-4 mm cutaneous papules, which develop into 
pustules, then crust over. A typical monkeypox lesion has a 
red, necrotic, depressed center, surrounded by epidermal 
hyperplasia. These “pocks” can be seen over the entire 
body, but may be more common on the face, limbs, palms, 
soles and tail. The number of lesions varies from a few 
individual pocks to extensive, coalescing lesions. The crusts 
over the pustules eventually drop off, leaving small scars. 
Some animals have only skin lesions. In more severe cases, 
there may also be respiratory signs (coughing, nasal 
discharge, dyspnea), anorexia, facial edema, oral ulcers or 
lymphadenopathy. Disseminated disease with visceral 
lesions is uncommon in natural infections among 
nonhuman primates. Pneumonia is common only in 
monkeys infected experimentally via aerosols.  
Most naturally infected animals recover; however, 
fatalities are sometimes seen, particularly in infant 
monkeys. Asymptomatic infections also occur. 
Prairie dogs 
In prairie dogs, the clinical signs may include fever, 
depression, anorexia, weight loss, nasal discharge, sneezing 
and/or coughing, respiratory distress, diarrhea, a nodular 
skin rash and oral ulcers. During the outbreak in the U.S., 
blepharoconjunctivitis was often the first sign. 
Lymphadenopathy has been reported in naturally infected 
prairie dogs, but did not occur in all experimentally infected 
animals. Elevated serum levels of liver enzymes have also 
been seen. In experimentally infected prairie dogs, skin 
lesions appeared first on the head or extremities, followed 
by the trunk. On the trunk and limbs, characteristic 
monkeypox lesions developed from macules through 
vesicles and pustules before forming scabs. Macules and 
vesicles also occurred on the face in this experiment, but 
pustules were not seen.  
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Infected prairie dogs may either recover or become 
fatally ill. Some experimentally infected prairie dogs died 1-2 
weeks after infection without developing lesions on the skin 
or mucous membranes. 
Other rodents 
Little is known about the effects of monkeypox virus 
on most rodent species. In dormice inoculated intranasally, 
the clinical signs were limited to lethargy, an unkempt hair 
coat, a hunched posture, conjunctivitis and dehydration. 
Many infections were fatal. Experimentally infected cotton 
rats developed an acute illness with rhinitis, conjunctivitis, 
dyspnea, coughing and progressive emaciation, often 
ending in death. In ground squirrels, the first signs were 
anorexia and lethargy. Nasal hemorrhages and dyspnea 
were common with a Congo Basin isolate, but most ground 
squirrels inoculated with a West African strain did not have 
nasal hemorrhages, and respiratory distress occurred only 
terminally. Both strains were uniformly fatal at the dose 
used.  
Fatal infections were reported among rope squirrels 
and one Gambian giant pouched rat in the shipment of 
exotic African rodents to the U.S. Mild clinical signs, with 
no respiratory signs and limited skin lesions, were seen in 
another Gambian giant pouched rat in the shipment. Some 
pouched rats that appeared healthy were seropositive. 
Post Mortem Lesions      Click to view images 
Recommended biological safety guidelines for the 
necropsy of infected animals have been published by the 
CDC (see Internet Resources).  
At necropsy, the skin may contain papules, 
umbilicated pustules (“pocks”) with central necrosis, or 
crusts over healing lesions. The skin lesions may vary 
from barely detectable, single small papules to extensive 
lesions. Ulcers, erosions or lesions with necrotic centers 
may be found in the mouths of some animals. Lesions 
(e.g., white plaques, or small, white, firm, deeply 
embedded foci with umbilicated necrotic centers) have 
sometimes been found on internal organs. Additional 
visceral lesions including (but not limited to) multifocal 
necrotizing pneumonitis, orchitis and peripheral 
lymphadenopathy may be seen. Blepharoconjunctivitis is 
a common finding in prairie dogs.  
In intranasally inoculated dormice, the gross lesions 
at necropsy included hepatomegaly, lymphadenopathy and 
hemorrhages in the upper gastrointestinal tract, nasal 
cavity, gall bladder and brain. Pulmonary edema and 
hemorrhages were reported in experimentally infected 
ground squirrels. 
Diagnostic Tests 
The characteristic skin lesions are suggestive of 
monkeypox, and histopathology provides supportive 
evidence. The diagnosis can be confirmed by virus isolation 
or polymerase chain reaction assay (PCR). Monkeypox 
virus can be recovered in mammalian cell cultures, and may 
be identified using PCR followed by restriction fragment–
length polymorphism (RFLP) analysis or sequencing. 
Monkeypox-specific PCR assays are available in some 
laboratories, and a DNA oligonucleotide microarray can 
identify this virus rapidly and specifically. PCR can also be 
performed directly on clinical samples.  
If the animal has not been exposed to other 
orthopoxviruses, monkeypox can be tentatively diagnosed 
by detecting orthopoxvirus virions with electron 
microscopy or orthopoxvirus antigens by immune-
histochemistry. However, the specific virus cannot be 
identified with these techniques.  
Serum, samples of skin lesions and conjunctival swabs 
may be collected from live animals. Monkeypox virus has 
also been detected in blood, and sometimes in oral and 
nasal secretions (e.g., oropharyngeal swabs), urine and 
feces. At necropsy, tissues should be collected from all 
organs that have lesions. In prairie dogs, monkeypox 
viruses, viral DNA or antigens have been detected in skin 
lesions, eyelid and tongue samples, and in many internal 
organs including the lung, liver, spleen and lymph nodes. In 
dormice, monkeypox viruses have been found in most 
organs and tissues. One study suggested that the liver 
contained particularly large amounts of virus in this species.  
Treatment  
Treatment is supportive, but may not be advisable or 
allowed in some situations. During the 2003 outbreak in 
the U.S., the CDC recommended that all animals with 
suspected monkeypox be euthanized to prevent zoonotic 
infections and reduce disease transmission to other 
animals. Nonhuman primates are not necessarily 
euthanized during outbreaks in facilities.  
Control 
Disease Reporting 
Veterinarians who encounter or suspect monkeypox 
should follow their national and/or local guidelines for 
disease reporting. In the U.S., state or federal authorities 
must be notified immediately. 
Prevention 
As a result of the 2003 outbreak, the U.S. banned the 
importation of six types of African rodents – sun squirrels 
(Heliosciurus sp.), rope squirrels (Funisciurus sp.), 
dormice, Gambian giant pouched rats, brush-tailed 
porcupines (Atherurus sp.), and striped mice (Hybomys sp.). 
These animals can no longer be imported except for 
scientific purposes, education or exhibition under a permit 
from the government. This ban applies to these animals 
whether they were born in Africa or on another continent. 
In addition, prairie dogs cannot be captured from the wild 
for use as pets. Exceptions to the restrictions are allowed, 
by permit, for organizations such as zoos. Similarly, some 
other countries and governing bodies such as the E.U. 
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banned the import of prairie dogs from the U.S., and some 
rodents from Africa. 
Good infection control measures, including the 
isolation of new animals, help prevent outbreaks in primate 
facilities. Care should be taken to avoid spreading the virus 
on fomites. Vaccination with vaccinia virus is protective. 
Because infections have been reported in Asian monkeys 
mixed with primates from Africa, these species should not 
be housed in the same area. Anyone who has been exposed 
to monkeypox should avoid contact with animals, 
particularly rodents and nonhuman primates, to avoid 
transmitting the virus to them. 
Morbidity and Mortality 
The prevalence of infection in wild primates is 
unknown. In one study, 8% of nonhuman primates in Africa 
were seropositive. Few outbreaks have been reported among 
captive primates. The morbidity rate is usually high and the 
mortality rate low; most adult animals recover. More severe 
illness may be seen in infants, which may die, as well as in 
cynomolgus monkeys, orangutans, and primates of all ages 
infected experimentally via aerosols. Cynomolgus monkeys 
developed more severe clinical signs after inoculation with a 
Congo Basin virus than a West African strain. 
Prairie dogs appear to be very susceptible to 
monkeypox. Mortality rates as high as 60% have been 
reported after experimental inoculation. During the U.S. 
outbreak, which was caused by a West African strain, 
some prairie dogs died rapidly, but others recovered. Little 
is known about the effects of monkeypox virus on other 
rodents, although fatal infections have been reported in 
some animals, including rope squirrels and dormice. 
Experimental infections in dormice, cotton rats and ground 
squirrels can result in mortality as high as 100%. Other 
rodents might be relatively resistant. During the outbreak in 
the U.S., monkeypox virus was found in one Gambian giant 
pouched rat that died soon after arrival. Another member of 
this species had a very mild illness, and orthopoxvirus 
antibodies were found in 12 of 18 healthy giant pouched 
rats after the outbreak.  
Infections in Humans 
Incubation Period 
The incubation period is reported to be 7 to 17 days, 
with a mean of 12 days, in Africa. In the U.S. outbreak, 
the incubation period was 4 to 24 days, with a mean of 
14.5 days.  
Clinical Signs 
In humans, monkeypox resembles smallpox; however, 
the symptoms are generally milder, and unlike smallpox, 
the lymph nodes are usually enlarged. The initial symptoms 
are flu–like and may include malaise, fever, chills, 
headache, sore throat, myalgia, backache, fatigue and a 
nonproductive cough. Lymphadenopathy most often affects 
the submandibular, postauricular, cervical and/or inguinal 
lymph nodes. Nausea, vomiting and conjunctivitis were 
reported from some cases in the U.S. A rash, initially 
characterized by macules and papules, develops one to 
several days after the prodromal signs; these lesions 
develop into vesicles and pustules (“pocks”), which 
umbilicate, form scabs and are eventually shed. The number 
of skin lesions varies from less than 25 to more than a 
hundred. They are usually concentrated on the extremities, 
but can also be seen on the head and torso. Lesions may 
develop on the mucous membranes, as well as on the palms, 
soles and genitalia. Confluent rashes and recurrent febrile 
periods can occur in severe cases. Corneal ulceration, 
coagulation disorders, respiratory complications including 
dyspnea, encephalitis (rarely) and multiorgan failure have 
also been reported. Although most patients survive, some 
cases end in death. In patients who recover, the illness 
generally lasts for 2 to 4 weeks, and the skin lesions usually 
resolve within 14 to 21 days. Residual varioliform scarring, 
with hypopigmented and/or hyperpigmented skin lesions, 
may be a sequela. Severe scarring, as seen in smallpox, is 
rare. Subclinical and very mild cases have also been 
reported.  
The 2003 monkeypox outbreak in the U.S., which was 
caused by a West African strain of the virus, differed in 
some respects from the classical description of the disease 
in Africa. Most people in the U.S. had a relatively mild 
form of the disease, with less marked lymphadenopathy 
than reported in Africa, relatively few lesions and a self-
limiting course. In many patients, the skin lesions were 
localized and confined to the extremities; generalized rash 
was rare. Some pustules had prominent erythematous flares; 
such flares have not been noted in African cases, possibly 
because most affected people have darker skin. In the U.S., 
skin lesions sometimes occurred at a bite or scratch, the 
apparent inoculation site, before systemic signs developed. 
The skin lesions usually healed without dyspigmented scars 
in this outbreak. Two severe cases were reported, both in 
children. One child developed encephalitis, a complication 
that had been reported only once before. The other child 
had generalized lesions including lesions in the oropharynx, 
and severe cervical and tonsillar lymphadenopathy, which 
caused difficulty in breathing and swallowing. An adult 
developed complications of keratitis and corneal ulceration, 
and received a corneal transplant. Patients with other 
symptoms of monkeypox and immunological evidence of 
exposure, but no skin lesions, were described in this 
outbreak. All patients recovered. 
Diagnostic Tests 
Monkeypox can be tentatively diagnosed if the 
characteristic skin lesions are present and there is a history 
of exposure. Tests to isolate the virus, or identify its nucleic 
acids or antigens, are similar to those used in animals. In 
humans, monkeypox virus can be found in skin lesions 
(e.g., in scabs or material from vesicles) or throat and 
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nasopharyngeal swabs. Serology may also be helpful. 
Convalescent-phase serum can be tested for orthopoxvirus-
specific IgM with an enzyme-linked immunosorbent assay 
(ELISA) if the lesions have resolved. Cross-reactions 
between orthopoxviruses, including smallpox and 
monkeypox viruses, can occur in serological tests. The 
possibility of exposure to undiscovered orthopoxviruses 
also complicates the interpretation of serology in endemic 
areas. Cross-adsorbed virus neutralization, 
immunofluorescence or hemagglutination inhibition assays, 
as well as immunoblotting (Western blotting), can be used 
to distinguish reactions between monkeypox virus and 
smallpox virus, although some of these assays are not 
always easy to interpret. A specific ELISA that may detect 
monkeypox antibodies in people vaccinated for smallpox 
has been reported in the literature.  
Treatment 
Treatment of monkeypox is mainly supportive. The 
antiretroviral drug cidofovir has been promising in vitro and 
in animal studies, but its efficacy against monkeypox in 
humans is unknown. The toxic effects of this drug must 
also be considered. The efficacy of vaccinia immune 
globulin (which was used to treat smallpox) in cases of 
monkeypox is unknown. 
Prevention 
Smallpox vaccination, particularly when recent, 
appears to provide some protection from monkeypox, and 
has been recommended for some groups at high risk of 
exposure. Post–exposure vaccination also seems to be 
helpful. The general population is not currently vaccinated 
in endemic areas of Africa. Any consideration of routine 
vaccination in healthy people must evaluate the risks and 
expense of the vaccine, as well as the benefits, in that 
population. Some people, including those with severe T cell 
immunodeficiencies, may not be able to receive the 
smallpox vaccine. 
As a routine preventive measure, care should be taken 
to treat and cover breaks in the skin when working with 
nonhuman primates or other animals that may be hosts for 
monkeypox virus. Infection control procedures such as 
good hygiene, frequent hand washing, disinfection of 
surfaces and equipment, and the use of personal protective 
equipment (PPE) are important during contact with animals 
suspected to have monkeypox. Necropsies should be done 
in Biosafety Level 2 laboratories, using a certified Class II 
Biological Safety Cabinet. The person performing the 
necropsy should have a recent smallpox vaccination and 
wear PPE. Anyone who has been in contact with a 
monkeypox suspect should contact a health care provider 
immediately. Health authorities (e.g., the local or state 
health department) must also be informed. 
Isolation of infected patients, good infection control 
measures and ring vaccination are helpful in preventing 
person-to-person transmission. Infected individuals are 
assumed to be contagious starting one day before the rash, 
and for up to 21 days after the initial symptoms (or until 
all scabs have separated and throat swabs are negative by 
PCR). Because the full host range of monkeypox virus is 
uncertain, infected individuals should also limit their 
contact with any pet, particularly species known to be 
susceptible.   
Morbidity and Mortality 
Case fatality rates of 0% to 33% have been reported 
during outbreaks of monkeypox in Africa. Congo Basin 
(Central African) strains of the virus, such as those found in 
the Democratic Republic of Congo (DRC), seem to cause 
more severe disease than the West African clade. In recent 
surveillance from the DRC, the case fatality rate was 
approximately 10-17%. The highest risk of death is in 
young children. Monkeypox seems to be less severe in 
people who have been vaccinated for smallpox, although 
the protection might decrease with time. 
In Africa, monkeypox is usually seen in rural 
populations, particularly in children. Most cases occur 
among people who live in or near heavily forested areas, 
where the virus is thought to be endemic in animals. 
Infections tend to occur after contact with wild small 
mammals, which are caught for food and other purposes. In 
the past, monkeypox was thought to be a rare disease; 
however, recent data from the Congo Basin may challenge 
that assumption. Active surveillance conducted in the DRC 
between 1981 and 1986 indicated an incidence of < 1 case 
per 10,000 population. In contrast, the average annual 
incidence in the central DRC was 5.5 cases per 10,000 
population (760 cases) during active surveillance from 2005 
to 2007. Passive surveillance programs reported 215 
possible monkeypox cases to the DRC Ministry of Health 
between 1998 and 2002, and 88 were subsequently 
confirmed by laboratory testing. Sporadic cases and 
outbreaks have also been documented in neighboring 
countries. Because most of these cases occurred in young 
people born after smallpox vaccination ended, some authors 
suggest that waning immunity may be contributing to an 
increase in the prevalence rate. Other societal factors (e.g., 
changes resulting from poverty or war) that increase 
exposure to the reservoir hosts are also plausible.  
Current information on monkeypox in residents of 
West Africa is limited. No outbreaks have been reported 
recently in endemic areas; however, these viruses are 
thought to cause milder illness than the Congo Basin clade, 
and cases might be underreported. In a recent survey from 
Ghana, antibodies to orthopoxviruses were found in 36% of 
young people who had not been vaccinated against 
smallpox and lived near a forest where monkeypox is 
endemic. These individuals frequently entered these forests, 
but reported no previous illness suggestive of this disease. 
Because it is difficult to distinguish antibodies to the 
various orthopoxviruses, the study could not exclude 
reactivity to other, unknown orthopoxviruses circulating in 
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the area. Another study reported serological evidence of 
recent exposure to orthopoxvirus(es) among young, 
unvaccinated individuals in Sierra Leone. 
The monkeypox outbreak in the U.S. was caused by a 
West African strain of the virus. In this outbreak, all human 
cases were associated with direct contact with pet prairie 
dogs, and not African rodents, although some of the latter 
animals had high viral titers. The types of behavioral 
interactions with different types of pets might have 
contributed to this phenomenon. (One case was originally 
thought to have been acquired from a rabbit, but testing by 
the CDC determined that the rabbit was not infected.) 
Seventy-two human infections were reported in this 
outbreak, with 37 of these laboratory confirmed. Most 
clinical cases were relatively mild. Severe disease occurred 
in two children, as the result of encephalitis or generalized 
monkeypox, but no deaths were reported. The availability 
of advanced health care facilities and good supportive care, 
as well as the absence of poor nutrition and concurrent 
diseases, may have contributed to the survival rate. The 
route of inoculation might also contribute to differences in 
clinical signs or severity; some people in Africa might be 
infected by ingestion during food preparation.  
Internet Resources 
Centers for Disease Control and Prevention (CDC). 
Monkeypox 
http://www.cdc.gov/ncidod/monkeypox/index.htm  
CDC necropsy guidelines for animals 
http://www.cdc.gov/ncidod/monkeypox/necropsy.htm* 
Wisconsin National Primate Research Center News and 
Outreach 
http://www.primate.wisc.edu/wprc/news.html 
World Health Organization. Monkeypox 
http://www.who.int/mediacentre/factsheets/fs161/en/  
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